Journey Strategic Wealth »

Larimar Therapeutics shares owned by Journey Strategic Wealth

Quarter-by-quarter ownership of Larimar Therapeutics (LRMR) shares owned by Journey Strategic Wealth from 13F filings

Historical chart of Journey Strategic Wealth investment in Larimar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Larimar Therapeutics held by Journey Strategic Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Larimar Therapeutics by Journey Strategic Wealth

Quarter filed Position value Share count Share price at filing
2023-12-31 $160k 35k 4.55
2023-09-30 $139k 35k 3.95
2023-06-30 $110k 35k 3.13

More positions owned by Journey Strategic Wealth

Johnson & Johnson (JNJ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Core S&p Scp Etf (IJR)
Pepsi (PEP)
Wisdomtree Tr Intl Qulty Div (IQDG)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Ishares Tr Esg Awr Msci Usa (ESGU)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Microsoft Corporation (MSFT)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Rus 1000 Etf (IWB)
Walt Disney Company (DIS)

View all positions for Journey Strategic Wealth

Top funds holding Larimar Therapeutics

Deerfield Management Company
Blue Owl Capital Holdings
Henderson Group
Vanguard Group
Citadel Advisors
Assenagon Asset Management
Opaleye Management
Ikarian Capital
Point72 Asset Management
DAFNA Capital Management
Atlas Venture Advisors
Deutsche Bank Aktiengesellschaft
Dimensional Fund Advisors
Goldman Sachs Group
J. Goldman & Co

View all funds holding Larimar Therapeutics